Chiorazzo, Michael G.
Tunset, Hanna Maja http://orcid.org/0000-0001-6960-2112
Popov, Anatoliy V.
Johansen, Berit
Moestue, Siver
Delikatny, E. James
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (T32 EB000814, R01-EB018645)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01 CA201328, R01 CA129176)
Kreftforeningen (2209215)
Norges Forskningsråd (239940 and 228879)
U.S. Department of Health & Human Services | NIH | NIH Office of the Director (S10 OD010688)
U.S. Department of Health & Human Services | NIH | National Center for Research Resources (UL1 RR024134)
Article History
Received: 23 September 2018
Accepted: 1 February 2019
First Online: 16 April 2019
Competing Interests
: B. Johansen has ownership interests (including patents) in Avexxin AS.